Literature DB >> 28396709

Human iPSC-derived myocardium-on-chip with capillary-like flow for personalized medicine.

Bradley W Ellis1, Aylin Acun1, U Isik Can2, Pinar Zorlutuna.   

Abstract

The heart wall tissue, or the myocardium, is one of the main targets in cardiovascular disease prevention and treatment. Animal models have not been sufficient in mimicking the human myocardium as evident by the very low clinical translation rates of cardiovascular drugs. Additionally, current in vitro models of the human myocardium possess several shortcomings such as lack of physiologically relevant co-culture of myocardial cells, lack of a 3D biomimetic environment, and the use of non-human cells. In this study, we address these shortcomings through the design and manufacture of a myocardium-on-chip (MOC) using 3D cell-laden hydrogel constructs and human induced pluripotent stem cell (hiPSC) derived myocardial cells. The MOC utilizes 3D spatially controlled co-culture of hiPSC derived cardiomyocytes (iCMs) and hiPSC derived endothelial cells (iECs) integrated among iCMs as well as in capillary-like side channels, to better mimic the microvasculature seen in native myocardium. We first fully characterized iCMs using immunostaining, genetic, and electrochemical analysis and iECs through immunostaining and alignment analysis to ensure their functionality, and then seeded these cells sequentially into the MOC device. We showed that iECs could be cultured within the microfluidic device without losing their phenotypic lineage commitment, and align with the flow upon physiological level shear stresses. We were able to incorporate iCMs within the device in a spatially controlled manner with the help of photocrosslinkable polymers. The iCMs were shown to be viable and functional within the device up to 7 days, and were integrated with the iECs. The iCMs and iECs in this study were derived from the same hiPSC cell line, essentially mimicking the myocardium of an individual human patient. Such devices are essential for personalized medicine studies where the individual drug response of patients with different genetic backgrounds can be tested in a physiologically relevant manner.

Entities:  

Year:  2017        PMID: 28396709      PMCID: PMC5367145          DOI: 10.1063/1.4978468

Source DB:  PubMed          Journal:  Biomicrofluidics        ISSN: 1932-1058            Impact factor:   2.800


  55 in total

1.  Endothelial cells promote cardiac myocyte survival and spatial reorganization: implications for cardiac regeneration.

Authors:  Daria A Narmoneva; Rada Vukmirovic; Michael E Davis; Roger D Kamm; Richard T Lee
Journal:  Circulation       Date:  2004-08-09       Impact factor: 29.690

Review 2.  Regenerating the heart.

Authors:  Michael A Laflamme; Charles E Murry
Journal:  Nat Biotechnol       Date:  2005-07       Impact factor: 54.908

Review 3.  Endothelial-cardiomyocyte interactions in cardiac development and repair.

Authors:  Patrick C H Hsieh; Michael E Davis; Laura K Lisowski; Richard T Lee
Journal:  Annu Rev Physiol       Date:  2006       Impact factor: 19.318

4.  Hypoxia inducible factor-1 activation by prolyl 4-hydroxylase-2 gene silencing attenuates myocardial ischemia reperfusion injury.

Authors:  Ramesh Natarajan; Fadi N Salloum; Bernard J Fisher; Rakesh C Kukreja; Alpha A Fowler
Journal:  Circ Res       Date:  2005-11-23       Impact factor: 17.367

5.  A simple and fast experimental model of myocardial infarction in the mouse.

Authors:  Jinfeng Wang; Huaben Bo; Xiangying Meng; Yin Wu; Yongli Bao; Yuxin Li
Journal:  Tex Heart Inst J       Date:  2006

6.  A novel model of cryoinjury-induced myocardial infarction in the mouse: a comparison with coronary artery ligation.

Authors:  Ewout J van den Bos; Barend M E Mees; Monique C de Waard; Rini de Crom; Dirk J Duncker
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-04-29       Impact factor: 4.733

7.  Quantitative measurement and control of oxygen levels in microfluidic poly(dimethylsiloxane) bioreactors during cell culture.

Authors:  Geeta Mehta; Khamir Mehta; Dhruv Sud; Jonathan W Song; Tommaso Bersano-Begey; Nobuyuki Futai; Yun Seok Heo; Mary-Ann Mycek; Jennifer J Linderman; Shuichi Takayama
Journal:  Biomed Microdevices       Date:  2007-04       Impact factor: 2.838

8.  Immunohistochemical expression of endothelial markers CD31, CD34, von Willebrand factor, and Fli-1 in normal human tissues.

Authors:  Marc P Pusztaszeri; Walter Seelentag; Fred T Bosman
Journal:  J Histochem Cytochem       Date:  2005-10-18       Impact factor: 2.479

9.  Hypoxia inducible factor-1 upregulates adiponectin in diabetic mouse hearts and attenuates post-ischemic injury.

Authors:  Ramesh Natarajan; Fadi N Salloum; Bernard J Fisher; Rakesh C Kukreja; Alpha A Fowler
Journal:  J Cardiovasc Pharmacol       Date:  2008-02       Impact factor: 3.105

Review 10.  VE-cadherin: the major endothelial adhesion molecule controlling cellular junctions and blood vessel formation.

Authors:  Dietmar Vestweber
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-12-27       Impact factor: 8.311

View more
  26 in total

Review 1.  Measuring and regulating oxygen levels in microphysiological systems: design, material, and sensor considerations.

Authors:  Kristina R Rivera; Murat A Yokus; Patrick D Erb; Vladimir A Pozdin; Michael Daniele
Journal:  Analyst       Date:  2019-05-13       Impact factor: 4.616

2.  CRISPR/Cas9 Edited Induced Pluripotent Stem Cell-Based Vascular Tissues to Model Aging and Disease-Dependent Impairment.

Authors:  Aylin Acun; Pinar Zorlutuna
Journal:  Tissue Eng Part A       Date:  2019-04-30       Impact factor: 3.845

Review 3.  Human-Derived Organ-on-a-Chip for Personalized Drug Development.

Authors:  Yasamin A Jodat; Min G Kang; Kiavash Kiaee; Gyeong J Kim; Angel F H Martinez; Aliza Rosenkranz; Hojae Bae; Su R Shin
Journal:  Curr Pharm Des       Date:  2018       Impact factor: 3.116

4.  In vitro aged, hiPSC-origin engineered heart tissue models with age-dependent functional deterioration to study myocardial infarction.

Authors:  Aylin Acun; Trung Dung Nguyen; Pinar Zorlutuna
Journal:  Acta Biomater       Date:  2019-05-27       Impact factor: 8.947

Review 5.  A Decade of Organs-on-a-Chip Emulating Human Physiology at the Microscale: A Critical Status Report on Progress in Toxicology and Pharmacology.

Authors:  Mario Rothbauer; Barbara E M Bachmann; Christoph Eilenberger; Sebastian R A Kratz; Sarah Spitz; Gregor Höll; Peter Ertl
Journal:  Micromachines (Basel)       Date:  2021-04-21       Impact factor: 2.891

6.  Transcriptome profiling of 3D co-cultured cardiomyocytes and endothelial cells under oxidative stress using a photocrosslinkable hydrogel system.

Authors:  Xiaoshan Yue; Aylin Acun; Pinar Zorlutuna
Journal:  Acta Biomater       Date:  2017-06-23       Impact factor: 8.947

Review 7.  Breast cancer models: Engineering the tumor microenvironment.

Authors:  Gokhan Bahcecioglu; Gozde Basara; Bradley W Ellis; Xiang Ren; Pinar Zorlutuna
Journal:  Acta Biomater       Date:  2020-02-09       Impact factor: 8.947

Review 8.  Multi-lineage Human iPSC-Derived Platforms for Disease Modeling and Drug Discovery.

Authors:  Arun Sharma; Samuel Sances; Michael J Workman; Clive N Svendsen
Journal:  Cell Stem Cell       Date:  2020-03-05       Impact factor: 24.633

9.  Designing Biomaterial Platforms for Cardiac Tissue and Disease Modeling.

Authors:  Andrew House; Iren Atalla; Eun Jung Lee; Murat Guvendiren
Journal:  Adv Nanobiomed Res       Date:  2020-10-16

10.  Adipose stem cell secretome markedly improves rodent heart and human induced pluripotent stem cell-derived cardiomyocyte recovery from cardioplegic transport solution exposure.

Authors:  Bradley W Ellis; Dmitry O Traktuev; Stephanie Merfeld-Clauss; Uryan Isik Can; Meijing Wang; Ray Bergeron; Pinar Zorlutuna; Keith L March
Journal:  Stem Cells       Date:  2020-12-23       Impact factor: 6.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.